2025-521235-37-00CompletedPhase 1
SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study).
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Jul 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- First submitted
- 2 May 2025
- Start date
- 15 Jul 2025
- Lead sponsor
- Fusion Pharmaceuticals Inc.
- EU CT number
- 2025-521235-37-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 45
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting | Amsterdam | Netherlands | Completed |
| Universitair Medisch Centrum Groningen | Groningen | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.